Hyderabad: According to experts and medical professionals, the incidence of Guillain-Barré syndrome (GBS) is currently ...

Damage to myelin, the protective sheath surrounding nerve fibers, impairs the brain's ability to transmit signals efficiently ...

Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases ...

Guillain-Barré Syndrome (GBS) is a rare autoimmune disorder where the immune system attacks peripheral nerves, causing ...

LPXTI-641 is under clinical development by Lapix Therapeutics and currently in Phase I for Demyelinating Diseases. According to GlobalData, Phase I drugs for Demyelinating Diseases have a 73% phase ...

Binge eating disorder can seriously affect a person’s physical and mental health. Cognitive behavioral therapy (CBT) is the most effective treatment. Healthcare professionals can prescribe it ...

Riliprubart is under clinical development by Sanofi and currently in Phase III for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). According to GlobalData, Phase III drugs for Chronic ...

Inflammatory bowel disease (IBD) is a group of intestinal disorders that cause prolonged inflammation of the digestive tract. It can include ulcerative colitis (UC) or Crohn’s disease.

Driven by scalable innovation and operational excellence, we aspire to fundamentally shift the way many allergic and inflammatory diseases are treated by targeting the mast cell,” said Kate Haviland, ...

An organic disease is one in which there is a measurable change to tissues, organs, or body systems. A functional disease is one in which there are abnormal symptoms or changes in function but with no ...

MS is a chronic disease caused by demyelination, often associated with a wide range of neurological symptoms, which despite the ability of existing drugs to control the inflammatory component of ...